Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.05B
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.42M
-
Shares change
-
-3.42M
-
Total reported value, excl. options
-
$4.01M
-
Value change
-
-$9.55M
-
Put/Call ratio
-
1.18
-
Number of buys
-
7
-
Number of sells
-
-14
-
Price
-
$2.81
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q2 2021
36 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q2 2021.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.42M shares
of 2.05B outstanding shares and own 0.07% of the company stock.
Largest 10 shareholders include Parkman Healthcare Partners LLC (734K shares), MORGAN STANLEY (227K shares), RENAISSANCE TECHNOLOGIES LLC (77.8K shares), LPL Financial LLC (66.1K shares), CITADEL ADVISORS LLC (45.1K shares), Intellectus Partners, LLC (40.5K shares), Game Plan Financial Advisors, LLC (29K shares), ACT Capital Management, LLC (27.5K shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (19K shares), and Cutter & CO Brokerage, Inc. (18.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.